These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12452302)

  • 1. Nicorandil-induced preconditioning as evidenced by troponin T measurements after coronary angioplasty in patients with stable angina pectoris.
    Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
    Jpn Heart J; 2002 Sep; 43(5):443-53. PubMed ID: 12452302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty.
    Yasuda T; Hashimura K; Matsu-ura Y; Kato Y; Ueda T; Mori I; Kijima Y
    Jpn Circ J; 2001 Jun; 65(6):526-30. PubMed ID: 11407735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.
    Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
    Circ J; 2002 Apr; 66(4):317-22. PubMed ID: 11954943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.
    Matsubara T; Minatoguchi S; Matsuo H; Hayakawa K; Segawa T; Matsuno Y; Watanabe S; Arai M; Uno Y; Kawasaki M; Noda T; Takemura G; Nishigaki K; Fujiwara H
    J Am Coll Cardiol; 2000 Feb; 35(2):345-51. PubMed ID: 10676679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning effect during coronary angioplasty in patients with stable angina pectoris.
    Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
    Intern Med; 2002 Jul; 41(7):509-15. PubMed ID: 12132516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil infusion leads to good recovery from ischemia of left ventricular regional work in comparison with nitroglycerin.
    Isobe N; Oshima S; Taniguchi K; Hoshizaki H; Adachi H; Toyama T; Naito S; Nogami A; Sugawara M
    Circ J; 2002 Oct; 66(10):943-8. PubMed ID: 12381090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of time interval between two balloon inflations on ischemic preconditioning during coronary angioplasty.
    Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
    Cathet Cardiovasc Diagn; 1997 Nov; 42(3):263-7. PubMed ID: 9367098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the time interval between the first and second balloon inflations on ischemic preconditioning during percutaneous transluminal coronary angioplasty].
    Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
    J Cardiol; 1996 Jun; 27(6):303-8. PubMed ID: 9062590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
    Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty.
    Kato T; Kamiyama T; Maruyama Y; Tanaka S; Yoshimoto N
    Am Heart J; 2001 Jun; 141(6):940-3. PubMed ID: 11376307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil.
    Matsuo H; Watanabe S; Segawa T; Yasuda S; Hirose T; Iwama M; Tanaka S; Yamaki T; Matsuno Y; Tomita M; Minatoguchi S; Fujiwara H
    Eur Heart J; 2003 Jul; 24(14):1296-303. PubMed ID: 12871686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.
    Leesar MA; Stoddard MF; Manchikalapudi S; Bolli R
    J Am Coll Cardiol; 1999 Sep; 34(3):639-50. PubMed ID: 10483942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning of human myocardium with adenosine during coronary angioplasty.
    Leesar MA; Stoddard M; Ahmed M; Broadbent J; Bolli R
    Circulation; 1997 Jun; 95(11):2500-7. PubMed ID: 9184580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome.
    Ohtani T; Ueda Y; Shimizu M; Mizote I; Hirayama A; Hori M; Kodama K
    Am Heart J; 2005 Aug; 150(2):227-33. PubMed ID: 16086923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiischemic effects of nicorandil during coronary angioplasty in humans.
    Saito S; Mizumura T; Takayama T; Honye J; Fukui T; Kamata T; Moriuchi M; Hibiya K; Tamura Y; Ozawa Y
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():257-63. PubMed ID: 7647030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Release of troponin T following PTCA in patients with unstable and stable angina pectoris].
    Ries MW; Rupprecht HJ; Dudsjak H; Hafner G; Meyer J
    Z Kardiol; 1999 Nov; 88(11):914-21. PubMed ID: 10643059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy.
    Kato T; Yoshimoto N
    Drugs; 2003; 63(2):133-8. PubMed ID: 12515561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nicorandil can reduce QT dispersion and prevent bradyarrhythmia during percutaneous transluminal coronary angioplasty of the right coronary artery.
    Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):179-84. PubMed ID: 15378138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.